Skip to main content
. Author manuscript; available in PMC: 2006 Jun 23.
Published in final edited form as: Nutr Clin Care. 2004;7(2):56–68.

Table 4.

Clinical Trials of Probiotics Used to Prevent Traveler’s Diarrhea (from Marteau et al.1)

Study Probiotic Study Size Probiotic Group vs. Control Group
Pozo-Olano, 1978 Lactobacillus acidophilus + Lactobacillus bulgaricus 50 35% vs. 29% (NS)
Kollaritsch, 1983 Lactobacilli 212 55% vs. 51% (NS)
Katelaris, 1995 Lactobacillus fermentum strain KLD 282 23.8% vs. 23.8% (NS)
Katelaris, 1995 L. acidophilus 282 25.7% vs. 23.8% (NS)
Black, 1989 L. acidophilus + Streptococcus thermophilus + Bifidobacterium bifidum + L. bulgaricus 81 43% vs. 71% (P = 0.02)
Kollaritsch von, 1993 Saccharomyces boulardii 1016 28.7% vs. 39.1% (P < 0.05)
Oksanea 1990 Lactobacillus rhamnosus GG 756 41% vs. 46.5% (P = 0.065)
Hilton, 1997 L. rhamnosus GG 245 3.9%/day vs. 7.4%/day (P = 0.05)